BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hannon G, Lysaght J, Liptrott NJ, Prina-Mello A. Immunotoxicity Considerations for Next Generation Cancer Nanomedicines. Adv Sci (Weinh) 2019;6:1900133. [PMID: 31592123 DOI: 10.1002/advs.201900133] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Xie Q, Liu Y, Long Y, Wang Z, Jiang S, Ahmed R, Daniyal M, Li B, Liu B, Wang W. Hybrid-cell membrane-coated nanocomplex-loaded chikusetsusaponin IVa methyl ester for a combinational therapy against breast cancer assisted by Ce6. Biomater Sci 2021;9:2991-3004. [DOI: 10.1039/d0bm02211j] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Polaka S, Makwana V, Vasdev N, Sheth A, Rajpoot K, Sengupta P, Tekade RK. Engineering immunity via skin-directed drug delivery devices. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.03.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Hrvat A, Schmidt M, Obholzer M, Benders S, Kollenda S, Horn PA, Epple M, Brandau S, Mallmann-gottschalk N. Reactivity of NK Cells Against Ovarian Cancer Cells Is Maintained in the Presence of Calcium Phosphate Nanoparticles. Front Immunol 2022;13:830938. [DOI: 10.3389/fimmu.2022.830938] [Reference Citation Analysis]
4 Li X, Li H, Zhang C, Pich A, Xing L, Shi X. Intelligent nanogels with self-adaptive responsiveness for improved tumor drug delivery and augmented chemotherapy. Bioact Mater 2021;6:3473-84. [PMID: 33869898 DOI: 10.1016/j.bioactmat.2021.03.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zhang H, Han W, Han J, Xu P, Jiang P. Review of novel materials as photosensitizers towards the bottleneck of photodynamic therapy. J Mater Sci. [DOI: 10.1007/s10853-022-07529-6] [Reference Citation Analysis]
6 Liao Z, Huang J, Lo PC, Lovell JF, Jin H, Yang K. Self-adjuvanting cancer nanovaccines. J Nanobiotechnology 2022;20:345. [PMID: 35883176 DOI: 10.1186/s12951-022-01545-z] [Reference Citation Analysis]
7 Dou Y, Zhao F, Li X, Guo Y. Monitoring Nitric Oxide-Induced Hypoxic Tumor Radiosensitization by Radiation-Activated Nanoagents under BOLD/DWI Imaging. ACS Biomater Sci Eng 2021;7:5242-54. [PMID: 34612040 DOI: 10.1021/acsbiomaterials.1c00543] [Reference Citation Analysis]
8 Li S, Guo X, Gao R, Sun M, Xu L, Xu C, Kuang H. Recent Progress on Biomaterials Fighting against Viruses. Adv Mater 2021;33:e2005424. [PMID: 33644954 DOI: 10.1002/adma.202005424] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
9 Popov AB, Melle F, Linnane E, González-López C, Ahmed I, Parshad B, Franck CO, Rahmoune H, Richards FM, Muñoz-Espín D, Jodrell DI, Fairen-Jimenez D, Fruk L. Size-tuneable and immunocompatible polymer nanocarriers for drug delivery in pancreatic cancer. Nanoscale 2022. [PMID: 35438701 DOI: 10.1039/d2nr00864e] [Reference Citation Analysis]
10 Hannon G, Prina-Mello A. Endotoxin contamination of engineered nanomaterials: Overcoming the hurdles associated with endotoxin testing. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;:e1738. [PMID: 34254460 DOI: 10.1002/wnan.1738] [Reference Citation Analysis]
11 Peres C, Matos AI, Moura LIF, Acúrcio RC, Carreira B, Pozzi S, Vaskovich-Koubi D, Kleiner R, Satchi-Fainaro R, Florindo HF. Preclinical models and technologies to advance nanovaccine development. Adv Drug Deliv Rev 2021;172:148-82. [PMID: 33711401 DOI: 10.1016/j.addr.2021.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Roma-Rodrigues C, Raposo LR, Valente R, Fernandes AR, Baptista PV. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1704. [PMID: 33565269 DOI: 10.1002/wnan.1704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ramos TI, Villacis-aguirre CA, López-aguilar KV, Santiago Padilla L, Altamirano C, Toledo JR, Santiago Vispo N. The Hitchhiker’s Guide to Human Therapeutic Nanoparticle Development. Pharmaceutics 2022;14:247. [DOI: 10.3390/pharmaceutics14020247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Fazal S, Lee R. Biomimetic Bacterial Membrane Vesicles for Drug Delivery Applications. Pharmaceutics 2021;13:1430. [PMID: 34575506 DOI: 10.3390/pharmaceutics13091430] [Reference Citation Analysis]
15 Brannon ER, Guevara MV, Pacifici NJ, Lee JK, Lewis JS, Eniola-adefeso O. Polymeric particle-based therapies for acute inflammatory diseases. Nat Rev Mater. [DOI: 10.1038/s41578-022-00458-5] [Reference Citation Analysis]
16 Gazzi A, Fusco L, Orecchioni M, Ferrari S, Franzoni G, Yan JS, Rieckher M, Peng G, Lucherelli MA, Vacchi IA, Chau NDQ, Criado A, Istif A, Mancino D, Dominguez A, Eckert H, Vázquez E, Ros TD, Nicolussi P, Palermo V, Schumacher B, Cuniberti G, Mai Y, Clementi C, Pasquali M, Feng X, Kostarelos K, Yilmazer A, Bedognetti D, Fadeel B, Prato M, Bianco A, Delogu LG. Graphene, other carbon nanomaterials and the immune system: toward nanoimmunity-by-design. J Phys Mater 2020;3:034009. [DOI: 10.1088/2515-7639/ab9317] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Li X, Naeem A, Xiao S, Hu L, Zhang J, Zheng Q. Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine. Pharmaceutics 2022;14:1292. [PMID: 35745863 DOI: 10.3390/pharmaceutics14061292] [Reference Citation Analysis]
18 Lafuente-Gómez N, Wang S, Fontana F, Dhanjani M, García-Soriano D, Correia A, Castellanos M, Rodriguez Diaz C, Salas G, Santos HA, Somoza Á. Synergistic immunomodulatory effect in macrophages mediated by magnetic nanoparticles modified with miRNAs. Nanoscale 2022. [PMID: 35904896 DOI: 10.1039/d2nr01767a] [Reference Citation Analysis]
19 Ding Y, Xu H, Xu C, Tong Z, Zhang S, Bai Y, Chen Y, Xu Q, Zhou L, Ding H, Sun Z, Yan S, Mao Z, Wang W. A Nanomedicine Fabricated from Gold Nanoparticles-Decorated Metal-Organic Framework for Cascade Chemo/Chemodynamic Cancer Therapy. Adv Sci (Weinh) 2020;7:2001060. [PMID: 32995124 DOI: 10.1002/advs.202001060] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 23.0] [Reference Citation Analysis]
20 Chua CYX, Ho J, Demaria S, Ferrari M, Grattoni A. Emerging Technologies for Local Cancer Treatment. Adv Therap 2020;3:2000027. [DOI: 10.1002/adtp.202000027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
21 Li Z, Liu Y, Fang X, Shu Z. Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy. Int J Nanomedicine 2021;16:1631-61. [PMID: 33688183 DOI: 10.2147/IJN.S290346] [Reference Citation Analysis]
22 Tutty MA, Movia D, Prina-Mello A. Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials. Drug Deliv Transl Res 2022. [PMID: 35507131 DOI: 10.1007/s13346-022-01147-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Izci M, Maksoudian C, Manshian BB, Soenen SJ. The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors. Chem Rev 2021;121:1746-803. [PMID: 33445874 DOI: 10.1021/acs.chemrev.0c00779] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
24 Ledesma F, Ozcan B, Sun X, Medina SM, Landry MP. Nanomaterial Strategies for Delivery of Therapeutic Cargoes. Adv Funct Materials 2022;32:2107174. [DOI: 10.1002/adfm.202107174] [Reference Citation Analysis]
25 Yu F, Wei C, Deng P, Peng T, Hu X. Deep exploration of random forest model boosts the interpretability of machine learning studies of complicated immune responses and lung burden of nanoparticles. Sci Adv 2021;7:eabf4130. [PMID: 34039604 DOI: 10.1126/sciadv.abf4130] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Giubilato E, Cazzagon V, Amorim MJB, Blosi M, Bouillard J, Bouwmeester H, Costa AL, Fadeel B, Fernandes TF, Fito C, Hauser M, Marcomini A, Nowack B, Pizzol L, Powell L, Prina-Mello A, Sarimveis H, Scott-Fordsmand JJ, Semenzin E, Stahlmecke B, Stone V, Vignes A, Wilkins T, Zabeo A, Tran L, Hristozov D. Risk Management Framework for Nano-Biomaterials Used in Medical Devices and Advanced Therapy Medicinal Products. Materials (Basel) 2020;13:E4532. [PMID: 33066064 DOI: 10.3390/ma13204532] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Gao S, Yang X, Xu J, Qiu N, Zhai G. Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment. ACS Nano 2021. [PMID: 34339170 DOI: 10.1021/acsnano.1c02103] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
28 Shakil MS, Niloy MS, Mahmud KM, Kamal MA, Islam MA. Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies. Cancers 2022;14:3047. [DOI: 10.3390/cancers14133047] [Reference Citation Analysis]
29 Gaffron F, Tilch A, Grüttner C, Kowalski A, Kramer M, Teichgräber U, Hilger AI. Challenges in Tracking of Fluorochrome-Labelled Nanoparticles in Mice via Whole Body NIRF Imaging. Nanomaterials (Basel) 2020;10:E596. [PMID: 32214019 DOI: 10.3390/nano10030596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Della Camera G, Lipsa D, Mehn D, Italiani P, Boraschi D, Gioria S. A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses. Int J Mol Sci 2021;22:E820. [PMID: 33467541 DOI: 10.3390/ijms22020820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Ferretti AM, Usseglio S, Mondini S, Drago C, La Mattina R, Chini B, Verderio C, Leonzino M, Cagnoli C, Joshi P, Boraschi D, Italiani P, Li Y, Swartzwelter BJ, Sironi L, Gelosa P, Castiglioni L, Guerrini U, Ponti A. Towards bio-compatible magnetic nanoparticles: Immune-related effects, in-vitro internalization, and in-vivo bio-distribution of zwitterionic ferrite nanoparticles with unexpected renal clearance. J Colloid Interface Sci 2021;582:678-700. [PMID: 32911414 DOI: 10.1016/j.jcis.2020.08.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]